AAAAAA
Results: 1-25/44
Authors:
JOHNSTON SRD
BROADLEY K
HENSON G
FISHER C
HENK M
GORE ME
Citation: Srd. Johnston et al., A DIFFICULT CASE - MANAGEMENT OF METASTATIC MELANOMA DURING PREGNANCY, BMJ. British medical journal, 316(7134), 1998, pp. 848-849
Authors:
JOHNSTON SRD
BROADLEY K
HENSON G
FISHER C
HENK M
GORE ME
Citation: Srd. Johnston et al., COMMENTARY - MANAGEMENT OF THE PATIENT, BMJ. British medical journal, 316(7134), 1998, pp. 851-851
Authors:
GORE ME
Citation: Me. Gore, THE GENE-THERAPY INDUSTRY - TECHNOLOGY TRIUMPHS OVER COMMON-SENSE, British Journal of Cancer, 78(2), 1998, pp. 143-143
Authors:
ADAMS M
CALVERT AH
CARMICHAEL J
CLARK PI
COLEMAN RE
EARL HM
GALLAGHER CJ
GANESAN TS
GORE ME
GRAHAM JD
HARPER PG
JAYSON GC
KAYE SB
LEDERMANN JA
OSBORNE RJ
PERREN TJ
POOLE CJ
RADFORD JA
RUSTIN GJS
SLEVIN ML
SMYTH JF
THOMAS H
WILKINSON PM
Citation: M. Adams et al., CHEMOTHERAPY FOR OVARIAN-CANCER - A CONSENSUS STATEMENT ON STANDARD PRACTICE, British Journal of Cancer, 78(11), 1998, pp. 1404-1406
Authors:
JOHNSTON SRD
CONSTENLA DO
MOORE J
ATKINSON H
AHERN RP
DADIAN G
RICHES PG
GORE ME
Citation: Srd. Johnston et al., RANDOMIZED PHASE-II TRIAL OF BCDT [CARMUSTINE (BCNU), CISPLATIN, DACARBAZINE (DTIC) AND TAMOXIFEN] WITH OR WITHOUT INTERFERON-ALPHA (IFN-ALPHA) AND INTERLEUKIN (IL-2) IN PATIENTS WITH METASTATIC MELANOMA, British Journal of Cancer, 77(8), 1998, pp. 1280-1286
Authors:
HILL ME
CONSTENLA DO
AHERN RP
HENK JM
RHYSEVANS P
BREACH N
ARCHER D
GORE ME
Citation: Me. Hill et al., CISPLATIN AND 5-FLUOROURACIL FOR SYMPTOM CONTROL IN ADVANCED SALIVARYADENOID CYSTIC CARCINOMA, Oral Oncology, 33(4), 1997, pp. 275-278
Authors:
MAINWARING PN
ATKINSON H
CHANG J
MOORE J
HANCOCK BW
GUILLOU PJ
OSKAM R
GORE ME
Citation: Pn. Mainwaring et al., DIFFERENTIAL RESPONSES TO CHEMOIMMUNOTHERAPY IN PATIENTS WITH METASTATIC MALIGNANT-MELANOMA, European journal of cancer, 33(9), 1997, pp. 1388-1392
Authors:
SAVAGE P
COSTELNA D
MOORE J
GORE ME
Citation: P. Savage et al., A PHASE-II STUDY OF CONTINUOUS INFUSIONAL 5-FLUOROURACIL (5-FU) AND SUBCUTANEOUS INTERLEUKIN-2 (IL-2) IN METASTATIC RENAL-CANCER, European journal of cancer, 33(7), 1997, pp. 1149-1151
Authors:
CONSTENLA DO
HILL ME
AHERN RP
HENK JM
RHYSEVANS P
BREACH N
ARCHER D
GORE ME
Citation: Do. Constenla et al., CHEMOTHERAPY FOR SYMPTOM CONTROL IN RECURRENT SQUAMOUS-CELL CARCINOMAOF THE HEAD AND NECK, Annals of oncology, 8(5), 1997, pp. 445-449
Authors:
HILL M
MACFARLANE V
MOORE J
GORE ME
Citation: M. Hill et al., TAXANE PLATINUM/ANTHRACYCLINE COMBINATION THERAPY IN ADVANCED EPITHELIAL OVARIAN-CANCER/, Seminars in oncology, 24(1), 1997, pp. 34-37
Authors:
HOLLOWAY BJ
GORE ME
AHERN RP
PARSONS C
Citation: Bj. Holloway et al., THE SIGNIFICANCE OF PARACARDIAC LYMPH-NODE ENLARGEMENT IN OVARIAN-CANCER, Clinical Radiology, 52(9), 1997, pp. 692-697
Authors:
GORE ME
RUSTIN G
SLEVIN M
GALLAGHER C
PENSON R
OSBORNE R
LEDERMANN J
CAMERON T
THOMPSON JM
Citation: Me. Gore et al., SINGLE-AGENT PACLITAXEL IN PATIENTS WITH PREVIOUSLY UNTREATED STAGE-IV EPITHELIAL OVARIAN-CANCER, British Journal of Cancer, 75(5), 1997, pp. 710-714
Authors:
AHMED FY
WILTSHAW E
AHERN RP
NICOL B
SHEPHERD J
BLAKE P
FISHER C
GORE ME
Citation: Fy. Ahmed et al., NATURAL-HISTORY AND PROGNOSIS OF UNTREATED STAGE-I EPITHELIAL OVARIAN-CARCINOMA, Journal of clinical oncology, 14(11), 1996, pp. 2968-2975
Authors:
CRAWFORD R
GORE ME
SHEPHERD JH
Citation: R. Crawford et al., OVARIAN CANCERS RELATED TO MINIMAL ACCESS SURGERY - REPLY, British journal of obstetrics and gynaecology, 103(2), 1996, pp. 185-186
Authors:
DEWIT D
FLEMMING CL
HARRIS JD
PALMER KJ
MOORE JS
GORE ME
COLLINS MKL
Citation: D. Dewit et al., IL-12 STIMULATION BUT NOT B7 EXPRESSION INCREASES MELANOMA KILLING BYPATIENT CYTOTOXIC T-LYMPHOCYTES (CTL), Clinical and experimental immunology, 105(2), 1996, pp. 353-359
Authors:
SAVAGE P
HORTON V
MOORE J
OWENS M
WITT P
GORE ME
Citation: P. Savage et al., A PHASE-I CLINICAL-TRIAL OF IMIQUIMOD, AN ORAL INTERFERON INDUCER, ADMINISTERED DAILY, British Journal of Cancer, 74(9), 1996, pp. 1482-1486
Authors:
AHMED FY
LEONARD GA
AHERN R
TAYLOR AE
LORENTZOS A
ATKINSON H
MOORE J
NICOLSON MC
RICHES PG
GORE ME
Citation: Fy. Ahmed et al., A RANDOMIZED DOSE-ESCALATION STUDY OF SUBCUTANEOUS INTERLEUKIN-2 WITHAND WITHOUT LEVAMISOLE IN PATIENTS WITH METASTATIC RENAL-CELL CARCINOMA OR MALIGNANT-MELANOMA, British Journal of Cancer, 74(7), 1996, pp. 1109-1113
Authors:
OBRIEN MER
MILAN S
CUNNINGHAM D
JONES AL
NICOLSON M
SELBY P
HICKISH T
HILL M
GORE ME
VINER C
Citation: Mer. Obrien et al., HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS BONE-MARROW TRANSPLANT IN RELAPSED HODGKINS-DISEASE - A PRAGMATIC PROGNOSTIC INDEX, British Journal of Cancer, 73(10), 1996, pp. 1272-1277
Authors:
SALTER J
MACLENNAN K
BRIDGEWATER JA
MOORE J
ATKINSON H
NICOLSON M
RICHES P
GORE ME
Citation: J. Salter et al., THE HISTOLOGICAL AND IMMUNOHISTOCHEMICAL CHANGES IN THE SKIN OF PATIENTS WITH MELANOMA WHO DEVELOP CHANGES IN SKIN PIGMENTATION FOLLOWING IMMUNOTHERAPY, Melanoma research, 5(4), 1995, pp. 267-271
Authors:
MAINWARING PN
GORE ME
Citation: Pn. Mainwaring et Me. Gore, THE IMPORTANCE OF DOSE AND SCHEDULE IN CANCER-CHEMOTHERAPY - EPITHELIAL OVARIAN-CANCER, Anti-cancer drugs, 6, 1995, pp. 29-41
Authors:
SHARPE JC
AHERN RP
FISHER C
BLAKE P
SHEPHERD J
GORE ME
Citation: Jc. Sharpe et al., CARCINOSARCOMA OF THE OVARY - INCIDENCE, PROGNOSIS, TREATMENT AND SURVIVAL OF PATIENTS, Annals of oncology, 6(8), 1995, pp. 755-758
Authors:
GORE ME
EARL HM
CASSIDY J
TATTERSALL M
MANSI J
SEYMOUR L
AZAB M
Citation: Me. Gore et al., A PHASE IN STUDY OF TOMUDEX IN RELAPSED EPITHELIAL OVARIAN-CANCER, Annals of oncology, 6(7), 1995, pp. 724-725
Authors:
CHANG J
FRYATT I
PONDER B
FISHER C
GORE ME
Citation: J. Chang et al., A MATCHED CONTROL STUDY OF FAMILIAL EPITHELIAL OVARIAN-CANCER - PATIENT CHARACTERISTICS, RESPONSE TO CHEMOTHERAPY AND OUTCOME, Annals of oncology, 6(1), 1995, pp. 80-82
Authors:
AHERN RP
GORE ME
Citation: Rp. Ahern et Me. Gore, IMPACT OF DOXORUBICIN ON SURVIVAL IN ADVANCED OVARIAN-CANCER, Journal of clinical oncology, 13(3), 1995, pp. 726-732
Authors:
SALTER J
MACLENNAN KA
MOORE J
DADIAN G
RICHES PG
GORE ME
Citation: J. Salter et al., THE PHENOTYPIC CHANGES IN TUMOR-INFILTRATING LYMPHOCYTES AND TUMOR-CELLS FOLLOWING INTRAARTERIAL INFUSION OF INTERLEUKIN-2 IN PATIENTS WITHSQUAMOUS-CELL CARCINOMA, Journal of pathology, 176(2), 1995, pp. 167-173